Title (COG ANHL1131) Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
Principal Investigator Matthew Barth, MD
Study Number 221412
Summary For the patients with advanced stage B-Cell NHL/B-AL to test whether adding 6 injections of rituximab to standard LMB chemotherapy regimen improves the EFS compared with LMB chemotherapy alone.
Eligibility Please see ClinicalTrials.gov link above.